[1] Christofori G. New signals from the invasive front[J]. Nature, 2006, 441(7092): 444-450. [2] Baranwal S, Alahari SK. Molecular mechanisms controlling E-cadherins expression in breast cancer [J]. Biochem Biophys Res Commun, 2009, 384(1): 6-11. [3] Hart GW, Copeland RJ. Glycomics hits the big time [J]. Cell, 2010, 143(5): 672-676. [4] Nita-Lazar M, Noonan V, Rebustini I, et al. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherins and cellular discohesion in oral cancer [J]. Cancer Res, 2009, 69(14): 5673-5680. [5] Liwosz A, Lei T, Kukuruzinska MA. N-glycosylation affects the molecular organization and stability of E-cadherins junctions [J]. J Biol Chem, 2006, 281(32): 23138-23149. [6] 郑家伟, 李金忠, 钟来平, 等. 口腔鳞状细胞癌临床流行病学研究现状 [J]. 中国口腔颌面外科杂志, 2007, 5(2): 83-90. [7] Hugo HJ, Kokkinos MI, Blick T, et al. Defining the E-cadherins repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study[J]. Cells Tissues Organs, 2011, 193(1-2): 23-40. [8] Thiery JP. Epithelial-mesenchymal transitions in tumour progression [J]. Nat Rev Cancer, 2002, 2(6): 442-454. [9] Espejo R, Rengifo-Cam W, Schaller MD, et al. PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells[J]. Am J Physiol Cell Physiol, 2010, 299(2): C454-463. [10] Mortazavi F, Dubinett S, Rettig M. c-Crk proto-oncogene contributes to transcriptional repression of p120-catenins in non-small cell lung cancer cells [J]. Clin Exp Metastasis, 2011, 28(4): 391-404. [11] Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression [J]. Biochim Biophys Acta, 1999, 1473(1): 21-34. [12] Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton [J]. Nat Cell Biol, 2002, 4(4): E101-108. [13] Pinho SS, Seruca R, Gärtner F, et al. Modulation of E-cadherins function and dysfunction by N-glycosylation [J]. Cell Mol Life Sci, 2011, 68(6): 1011-1020. [14] Zhao YY, Takahashi M, Gu JG, et al. Functional roles of N-glycans in cell signaling and cell adhesion in cancer [J]. Cancer Sci, 2008, 99(7): 1304-1310. [15] Freeze HH. Genetic defects in the human glycome [J]. Nat Rev Genet, 2006, 7(7): 537-551. [16] Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer[J]. Nat Rev Cancer,2004, 4(2): 118-132. [17] Lewis-Tuffin LJ, Rodriguez F, Giannini C, et al. Misregulated E-cadherins expression associated with an aggressive brain tumor phenotype [J]. PLoS One, 2010, 5(10): e13665. [18] Lau MT, Klausen C, Leung PC. E-cadherins inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenins-Egr1-mediated PTEN expression [J]. Oncogene, 2011, 30(24): 2753-2766. [19] de Freitas Junior JC, Silva Bdu R, de Souza WF, et al. Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell-cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells [J]. Cancer Chemother Pharmacol, 2011, 68(1): 227-238. |